Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001371087 | SCV001567641 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2022-12-12 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MCCC2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MCCC2 protein function. ClinVar contains an entry for this variant (Variation ID: 1061496). This variant is present in population databases (rs376237028, gnomAD 0.02%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 284 of the MCCC2 protein (p.Leu284Pro). |
Natera, |
RCV001371087 | SCV002084910 | uncertain significance | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-04-16 | no assertion criteria provided | clinical testing |